KEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC)

被引：0

作者：

Zhou, C. ^{[1
]}

Caglevic, C. ^{[2
]}

Zhou, J. ^{[3
]}

Wang, B. ^{[4
]}

Wang, K. ^{[5
]}

Ge, J. ^{[6
]}

Zhou, Y. ^{[6
]}

Piperdi, B. ^{[7
]}

Ma, Z. ^{[8
]}

机构：

[1] Shanghai Pulm Hosp, Dept Oncol, Shanghai, Peoples R China

[2] FALP, Dept Oncol, Santiago, Chile

[3] Zhejiang Univ, Hosp 1, Dept Respirat, Hangzhou, Zhejiang, Peoples R China

[4] Subei Peoples Hosp, Dept Oncol, Yangzhou, Jiangsu, Peoples R China

[5] Zhejiang Univ, Hosp 2, Dept Respirat, Hangzhou, Zhejiang, Peoples R China

[6] MSD China, Oncol, Shanghai, Peoples R China

[7] Merck & Co Inc, Oncol, Kenilworth, NJ USA

[8] Henan Canc Hosp, Dept Oncol, Zhengzhou, Henan, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

466TiP

引用

页码：143 / 143

页数：1

共 50 条

[31] Phase III study of vinflunine versus docetaxel in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) previously treated with a platinum containing regimen [J].

Ramlau, Rodryg ;

Bennouna, Jaafar ;

Tan, Eng Huat ;

Biesma, Bonne ;

Santoro, Armando ;

Boni, Corrado ;

Klein, Helmut ;

Lesniewski, Krzysztof ;

Mesia, Ricard ;

Gatzemeier, Urlich .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :S317-S318

[32] Cost-Effectiveness of Tislelizumab Versus Docetaxel for Previously Treated Advanced Non-Small-Cell Lung Cancer in China [J].

Gong, Jinhong ;

Su, Dan ;

Shang, Jingjing ;

Xu, Shan ;

Tang, Lidan ;

Sun, Zhiqiang ;

Liu, Guangjun .

FRONTIERS IN PHARMACOLOGY, 2022, 13

[33] Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containing regimen [J].

Krzakowski, M. ;

Douillard, J. ;

Ramlau, R. ;

Jassem, J. ;

Szczesna, A. ;

Zatloukal, P. ;

von Pawel, J. ;

Hansen, O. ;

Sun, X. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)

[34] A cost utility analysis of erlotinib in patients with previously treated advanced non-small-cell lung cancer (NSCLC) [J].

Bradbury, P. A. ;

Jang, R. ;

Isogai, P. ;

Mittmann, N. ;

Evans, W. ;

Shepherd, F. A. ;

Leighl, N. B. ;

Ng, R. .

VALUE IN HEALTH, 2008, 11 (03) :A72-A72

[35] Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer [J].

Gerber, D. F. ;

Horn, L. ;

Boyer, M. ;

Sanborn, R. ;

Natale, R. ;

Palmero, R. ;

Bidoli, P. ;

Bondarenko, I. ;

Germonpre, P. ;

Ghizdavescu, D. ;

Kotsakis, A. ;

Lena, H. ;

Losonczy, G. ;

Park, K. ;

Su, W-C ;

Tang, M. ;

Lai, J. ;

Kallinteris, N. L. ;

Shan, J. S. ;

Reck, M. ;

Spigel, D. R. .

ANNALS OF ONCOLOGY, 2018, 29 (07) :1548-1553

[36] KEYNOTE-025: Phase 1b study of pembrolizumab (pembro) in Japanese patients (pts) with previously treated PD-L1+non-small cell lung cancer (NSCLC) [J].

Kato, T. ;

Takahashi, T. ;

Yoshioka, H. ;

Nakagawa, K. ;

Maemondo, M. ;

Yamada, K. ;

Ichiki, M. ;

Tanaka, H. ;

Seto, T. ;

Sakai, H. ;

Kasahara, K. ;

Satouchi, M. ;

Noguchi, K. ;

Shimamoto, T. ;

Nishio, M. .

ANNALS OF ONCOLOGY, 2016, 27

[37] Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer [J].

Millward, MJ ;

Zalcberg, J ;

Bishop, JF ;

Webster, LK ;

Zimet, A ;

Rischin, D ;

Toner, GC ;

Laird, J ;

Cosolo, W ;

Urch, M ;

Bruno, R ;

Loret, C ;

James, R ;

Blanc, C .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :750-758

[38] Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy [J].

Esteban, E ;

de Sande, LG ;

Fernández, Y ;

Corral, N ;

Fra, J ;

Muniz, I ;

Vieitez, JM ;

Palacio, I ;

Fernández, JL ;

Estrada, E ;

Lacave, AJ .

ANNALS OF ONCOLOGY, 2003, 14 (11) :1640-1647

[39] Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer [J].

Fanucchi, Michael P. ;

Fossella, Frank V. ;

Belt, Robert ;

Natale, Ronald ;

Fidias, Panos ;

Carbone, David P. ;

Govindan, Ramaswamy ;

Raez, Luis E. ;

Robert, Francisco ;

Ribeiro, Maria ;

Akerley, Wallace ;

Kelly, Karen ;

Limentani, Steven A. ;

Crawford, Jeffrey ;

Reimers, Hans-Joachim ;

Axelrod, Rita ;

Kashala, Oscar ;

Sheng, Shihong ;

Schiller, Joan H. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) :5025-5033

[40] Effect of Amrubicin in Patients with Previously Treated Non-Small-Cell Lung Cancer [J].

Takayama, S. ;

Tamura, T. ;

Kawajiri, T. ;

Nishi, T. ;

Kudo, K. ;

Kuyama, S. ;

Kawakado, K. .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S937-S937

← 1 2 3 4 5 →